Guideline-discordant prostate cancer imaging up with Medicare
(HealthDay)—Patients with prostate cancer receiving care in a Medicare-only setting are more likely to receive guideline-discordant imaging, according to a study published online Aug. 17 in JAMA Network Open.
Sep 12, 2018
0
1